I am always challenged and intellectually stimulated when I feel as though I’ve identified a pattern, practice, or even consequence of doing business that reveals itself as I observe the fledgling industry that we’ve alchemized and branded here in the U.S. as our version of “Regenerative Medicine." Aside from the fact that we’re in many ways “catching up” to our international neighbors in the delivery of treatments in clinic, we continue to innovate at lightening pace, and it

Throughout the week of August 7th, I have visits in DC with top policymakers and regulators, politicians, stem cell industry leaders, resear